WO2002015870A3 - Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut - Google Patents

Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut Download PDF

Info

Publication number
WO2002015870A3
WO2002015870A3 PCT/EP2001/009658 EP0109658W WO0215870A3 WO 2002015870 A3 WO2002015870 A3 WO 2002015870A3 EP 0109658 W EP0109658 W EP 0109658W WO 0215870 A3 WO0215870 A3 WO 0215870A3
Authority
WO
WIPO (PCT)
Prior art keywords
substances
skin
intensifying
inducing
tanning
Prior art date
Application number
PCT/EP2001/009658
Other languages
English (en)
French (fr)
Other versions
WO2002015870A2 (de
Inventor
Thomas Blatt
Werner Berens
Franz Staeb
Rainer Wolber
Original Assignee
Beiersdorf Ag
Thomas Blatt
Werner Berens
Franz Staeb
Rainer Wolber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag, Thomas Blatt, Werner Berens, Franz Staeb, Rainer Wolber filed Critical Beiersdorf Ag
Priority to EP01980254A priority Critical patent/EP1311234A2/de
Publication of WO2002015870A2 publication Critical patent/WO2002015870A2/de
Publication of WO2002015870A3 publication Critical patent/WO2002015870A3/de
Priority to US10/373,341 priority patent/US20040076597A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

Verwendung einer oder mehrerer Substanzen, welche gewählt werden aus der Gruppe der AGEs und/oder deren Vorläufern, zur Bräunung der Haut und kosmetische oder dermatologische Formulierungen solche Substanzen enthaltend.
PCT/EP2001/009658 2000-08-24 2001-08-21 Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut WO2002015870A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01980254A EP1311234A2 (de) 2000-08-24 2001-08-21 Substanzen zur induktion und intensivierung der bräunungsmechanismen der haut
US10/373,341 US20040076597A1 (en) 2000-08-24 2003-02-24 Substances for inducing or intensifying the tanning mechanisms of the skin and cosmetic or dermatological formulations comprising same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10041482.6 2000-08-24
DE10041482A DE10041482A1 (de) 2000-08-24 2000-08-24 Substanzen zur Induktion und Intensivierung der Bräunungsmechanismen der Haut und kosmetische oder dermatologische Formulierungen dieselben enthaltend

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/373,341 Continuation US20040076597A1 (en) 2000-08-24 2003-02-24 Substances for inducing or intensifying the tanning mechanisms of the skin and cosmetic or dermatological formulations comprising same

Publications (2)

Publication Number Publication Date
WO2002015870A2 WO2002015870A2 (de) 2002-02-28
WO2002015870A3 true WO2002015870A3 (de) 2002-07-18

Family

ID=7653579

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/009658 WO2002015870A2 (de) 2000-08-24 2001-08-21 Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut

Country Status (4)

Country Link
US (1) US20040076597A1 (de)
EP (1) EP1311234A2 (de)
DE (1) DE10041482A1 (de)
WO (1) WO2002015870A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10160966A1 (de) * 2001-12-12 2003-06-26 Beiersdorf Ag Melaninbildendes Haarfärbungsprodukt
EP1510211A1 (de) * 2003-08-26 2005-03-02 Lynkeus Biotech GmbH Pharmazeutische Zusammensetzung enthaltend N-Retinyl-N-Retinylidenethanolamin (a2e), Isoformen oder Derivate
DE10341654A1 (de) * 2003-09-08 2005-04-07 Beiersdorf Ag Mittel zur Anwendung auf der Haut und/oder dem Haar enthaltend 4-fach substituierte Cyclohexen-Verbindungen
US20080311058A1 (en) * 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
DE102007032393A1 (de) * 2007-07-10 2009-01-29 Henkel Ag & Co. Kgaa Advanced Glycation Endproducts als Wirkstoffe
ES2710498T3 (es) 2007-12-26 2019-04-25 Mark A Pinsky Formulaciones de colágeno para la mejora del cuidado de la piel
DE102008059703A1 (de) 2008-12-01 2010-06-02 Henkel Ag & Co. Kgaa Neue kosmetische Zusammensetzungen mit haarwuchsinhibierender Wirkung
DE102008059765A1 (de) 2008-12-01 2010-06-02 Henkel Ag & Co. Kgaa Neue Deodorantien und Antitranspirantien mit haarwuchsinhibierender Wirkung
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
US8398959B2 (en) 2010-12-06 2013-03-19 Conopco, Inc. Compositions and methods for imparting a sunless tan with functionalized adjuvants
CN103826702B (zh) 2011-09-26 2017-02-15 荷兰联合利华有限公司 头发组合物
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
DE102014202704A1 (de) * 2014-02-14 2015-08-20 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Decalinderivaten und Verwendung von Decalinderivaten zur Bräunung der Haut

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307939A1 (de) * 1987-09-17 1989-03-22 The Rockefeller University Glycosylierte Endstoffe und damit verbundene Verfahren
US5214138A (en) * 1989-12-20 1993-05-25 Case Western Reserve University Imidazopyridinium compound and processes for isolating, identifying, and chemically synthesizing same
WO1994020083A1 (en) * 1993-03-11 1994-09-15 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801200A (en) * 1984-03-19 1998-09-01 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5700447A (en) * 1992-05-21 1997-12-23 The Picowder Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5288615A (en) * 1984-03-19 1994-02-22 The Rockefeller University Methods for preparing proteins of altered structure
US5733933A (en) * 1984-03-19 1998-03-31 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5733524A (en) * 1984-03-19 1998-03-31 The Picower Institute For Medical Research Methods and materials for the diagnosis and treatment of conditions such as stroke
US5126442A (en) * 1987-09-17 1992-06-30 The Rockefeller University Advanced glycosylation endproducts and associated methods
US5017696A (en) * 1987-09-17 1991-05-21 The Rockefeller University Advanced glycosylation end products and associated methods
US5480807A (en) * 1989-12-20 1996-01-02 Case Western Reserve University Process for assessing the biological age of a tissue
US5374712A (en) * 1989-12-20 1994-12-20 Case Western Reserve University Imidazopyridinium compound and processes for isolating, identifying, and chemically synthesizing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0307939A1 (de) * 1987-09-17 1989-03-22 The Rockefeller University Glycosylierte Endstoffe und damit verbundene Verfahren
US5214138A (en) * 1989-12-20 1993-05-25 Case Western Reserve University Imidazopyridinium compound and processes for isolating, identifying, and chemically synthesizing same
WO1994020083A1 (en) * 1993-03-11 1994-09-15 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; ELDRED, G.E.: "Lipofuscin fluorophore inhibits lysosomal protein degradation and may cause early stages of macular degeneration", XP002188191, retrieved from STN Database accession no. 124:256879 *
GERONTOLOGY (BASEL) (1995), VOLUME DATE 1995, 41(SUPPL. 2), 15-28 *
NJOROGE, F.G., FERNANDES, A.A., MONNIER, V.M.: "Mechanism of formation of the putative advanced glycosilation end product and protein cross-link 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 263, no. 22, 1988, pages 10646 - 10652, XP002188190 *
NJOROGE,F.G. AND MONNIER, V. M.: "The chemistry of the Maillard reaction under physiological conditions: a review", PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH, vol. 304, 1989, pages 85 - 107, XP001053049 *

Also Published As

Publication number Publication date
WO2002015870A2 (de) 2002-02-28
US20040076597A1 (en) 2004-04-22
EP1311234A2 (de) 2003-05-21
DE10041482A1 (de) 2002-03-07

Similar Documents

Publication Publication Date Title
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
BR0005786B1 (pt) composiÇço de cosmÉtico para o tratamento de cabelo ou pele.
BR0211251B1 (pt) composição para o tratamento de cabelo e/ou couro cabeludo.
WO2003053383A3 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
BR9801355B1 (pt) emulsço àleo-em-Água, composiÇço cosmÉtica de uso tàpico, utilizaÇço de uma emulsço, processo de tratamento nço terapÊutico da pele e processo de preparaÇço de uma emulsço.
WO2002015870A3 (de) Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut
ATE468889T1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
BR9704843B1 (pt) hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano.
EP1125574A3 (de) Kosmetische und pharmazeutische Öl-in-Wasser-Emulsionen von polyethermodifizierten Polysiloxanen
WO2003057134A8 (en) Specific binding agents of human angiopoietin-2
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AR002974A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparación de una composición cosmética, farmacéutica y/o dermatológica para tratar las manchas rojas cutáneas de origen neurógeno, composición obtenida y procedimiento de tratamiento cosmético empleando dicho antagonista.
HUP0105058A2 (hu) Perifériás benzodiazepin receptorhoz kötődő anyag alkalmazása kutánstressz kezelésére
MXPA02002118A (es) Composiciones que contienen productos leguminosos.
BR9903336B1 (pt) composição cosmética, usos da composição e processo para o tratamento cosmético de substáncias queratìnicas.
WO2002076494A3 (en) USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
EP1240891A3 (de) Mittel zum Färben von menschlichen Haaren
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
EP1236465A3 (de) Verwendung von Gemüseprodukten zur Behandlung äusserer schädlicher Einflüsse
WO2002098347A3 (en) Methods and compositions that affect melanogenesis (pfi-016cip/pct)
MXPA02002119A (es) Productos leguminosos.
WO2002102340A3 (de) Verwendung von carnitin und/oder einem oder mehreren acyl-carnitinen zur herstellung von kosmetischen oder dermatologischen zubereitungen
WO2002036090A3 (de) Kosmetische pflaster zur hautaufhellung

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2001980254

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10373341

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001980254

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001980254

Country of ref document: EP